1,393
Views
1
CrossRef citations to date
0
Altmetric
Real-World Evidence and Medical Affairs

Patients’ experience and utilization patterns of diclofenac gel in Germany: a real-world study with a prospective longitudinal survey and a retrospective analysis of pharmacy data

, , , , , & show all
Pages 1649-1661 | Received 14 Apr 2023, Accepted 31 Jul 2023, Published online: 11 Aug 2023

References

  • Cieza A, Causey K, Kamenov K, et al. Global estimates of the need for rehabilitation based on the global burden of disease study 2019: a systematic analysis for the Global Burden of Disease Study 2019. The. Lancet. 2021;396(10267):2006–2017. doi:10.1016/S0140-6736(20)32340-0.
  • Fuchs J, Rabenberg M, Scheidt-Nave C. Prävalenz ausgewählter muskuloskelettaler Erkrankungen. 2013.
  • Schmidt CO, Raspe H, Pfingsten M, et al. Back pain in the German adult population: prevalence, severity, and sociodemographic correlates in a multiregional survey. Spine. 2007;32(18):2005–2011. doi:10.1097/BRS.0b013e318133fad8.
  • Überall MA. Praxisleitfaden zu akuten Kreuz-und Rückenschmerzen. MMW – Fortschritte der Medizin. 2022;164:12–17.
  • Schnitzer TJ. Update on guidelines for the treatment of chronic musculoskeletal pain. Clin Rheumatol. 2006;25(Suppl 1):S22–S29. doi:10.1007/s10067-006-0203-8.
  • Pergolizzi J, Böger RH, Budd K, et al. Opioids and the management of chronic severe pain in the elderly: consensus statement of an international expert panel with focus on the six clinically most often used world health organization step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract. 2008;8(4):287–313. doi:10.1111/j.1533-2500.2008.00204.x.
  • Buchman AS, Shah RC, Leurgans SE, et al. Musculoskeletal pain and incident disability in community‐dwelling older adults. Arthritis Care Res. 2010;62(9):1287–1293. doi:10.1002/acr.20200.
  • da Silveira MM, Potulski AP, Vidmar MF, et al. Atividade Física e Qualidade de Vida em Idosos. Saúde e Pesquisa. 2011;4(3):417.
  • Hagen M, Madhavan T, Bell J. Combined analysis of 3 cross-sectional surveys of pain in 14 countries in Europe, the Americas, Australia, and Asia: impact on physical and emotional aspects and quality of life. Scand J Pain. 2020;20(3):575–589. doi:10.1515/sjpain-2020-0003.
  • Mason L, Moore RA, Edwards JE, et al. Topical NSAIDs for acute pain: a meta-analysis. BMC Fam Pract. 2004;5:10. doi:10.1186/1471-2296-5-10.
  • Mason L, Moore RA, Edwards JE, et al. Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis. BMC Musculoskelet Disord. 2004;5:28. doi:10.1186/1471-2474-5-28.
  • Hagen M, Baker M. Skin penetration and tissue permeation after topical administration of diclofenac. Curr Med Res Opin. 2017;33(9):1623–1634. doi:10.1080/03007995.2017.1352497.
  • Schmidt M, Sørensen HT, Pedersen L. Diclofenac use and cardiovascular risks: series of nationwide cohort studies. BMJ. 2018;362:k3426. doi:10.1136/bmj.k3426.
  • Derry S, Moore RA, Gaskell H, et al. Topical NSAIDs for acute musculoskeletal pain in adults. Cochrane Database Syst Rev. 2015;2015(6):CD007402.
  • McPherson ML, Cimino NM. Topical NSAID formulations. Pain Med. 2013;14(Suppl 1):S35–S39. doi:10.1111/pme.12288.
  • Niethard FU, Gold MS, Solomon GS, et al. Efficacy of topical diclofenac diethylamine gel in osteoarthritis of the knee. J Rheumatol. 2005;32(12):2384–2392.
  • Predel HG, Giannetti B, Pabst H, et al. Efficacy and safety of diclofenac diethylamine 1.16% gel in acute neck pain: a randomized, double-blind, placebo-controlled study. BMC Musculoskelet Disord. 2013;14:250. doi:10.1186/1471-2474-14-250.
  • Zacher J, Burger KJ, Färber L, et al. Topical diclofenac versus oral ibuprofen: a double blind, randomized clinical trial to demonstrate efficacy and tolerability in patients with activated osteoarthritis of the finger joints (Heberden and/or Bouchard Arthritis). Akt Rheumatol. 2001;26(1):7–14. doi:10.1055/s-2001-11369.
  • Predel HG, Hamelsky S, Gold M, et al. Efficacy and safety of diclofenac diethylamine 2.32% gel in acute ankle sprain. Med Sci Sports Exerc. 2012; Sep44(9):1629–1636. doi:10.1249/MSS.0b013e318257ed41.
  • Yin F, Ma J, Xiao H, et al. Randomized, double-blind, noninferiority study of diclofenac diethylamine 2.32% gel applied twice daily versus diclofenac diethylamine 1.16% gel applied four times daily in patients with acute ankle sprain. BMC Musculoskelet Disord. 2022;23(1):1125. doi:10.1186/s12891-022-06077-z.
  • Poquet N, Lin C. The brief pain inventory (BPI). J Physiother. 2016;62(1):52. doi:10.1016/j.jphys.2015.07.001.
  • Tait RC, Pollard CA, Margolis RB, et al. The pain disability index: psychometric and validity data. Arch Phys Med Rehabil. 1987;68(7):438–441.
  • Jensen MP, Turner JA, Romano JM, et al. Comparative reliability and validity of chronic pain intensity measures. Pain. 1999;83(2):157–162. doi:10.1016/s0304-3959(99)00101-3.
  • Kapstad H, Hanestad BR, Langeland N, et al. Cutpoints for mild, moderate and severe pain in patients with osteoarthritis of the hip or knee ready for joint replacement surgery. BMC Musculoskelet Disord. 2008;9:55. doi:10.1186/1471-2474-9-55.
  • Li KK, Harris K, Hadi S, et al. What should be the optimal cut points for mild, moderate, and severe pain? J Palliat Med. 2007;10(6):1338–1346. doi:10.1089/jpm.2007.0087.
  • Boonstra AM, Stewart RE, Koke AJ, et al. Cut-off points for mild, moderate, and severe pain on the numeric rating scale for pain in patients with chronic musculoskeletal pain: variability and influence of sex and catastrophizing. Front Psychol. 2016;7:1466. doi:10.3389/fpsyg.2016.01466.
  • Qaseem A, McLean RM, O’Gurek D, et al. Nonpharmacologic and pharmacologic management of acute pain from non-low back, musculoskeletal injuries in adults: a clinical guideline from the American college of physicians and American academy of family physicians. Ann Intern Med. 2020;173(9):739–748. doi:10.7326/M19-3602.
  • Rafanan BS, Jr., Valdecanas BF, Lim BP, et al. Consensus recommendations for managing osteoarthritic pain with topical NSAIDs in Asia-pacific. Pain Manag. 2018;8(2):115–128. doi:10.2217/pmt-2017-0047.
  • Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthr Cartil. 2019;27(11):1578–1589. doi:10.1016/j.joca.2019.06.011.
  • Bruyere O, Cooper C, Pelletier JP, et al. A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis-From evidence-based medicine to the real-life setting. Semin Arthritis Rheum. 2016;45(4 Suppl):S3–S11. doi:10.1016/j.semarthrit.2015.11.010.
  • Kloppenburg M, Kroon FP, Blanco FJ, et al. 2018 Update of the EULAR recommendations for the management of hand osteoarthritis. Ann Rheum Dis. 2019;78(1):16–24. doi:10.1136/annrheumdis-2018-213826.
  • Rillo O, Riera H, Acosta C, et al. PANLAR consensus recommendations for the management in osteoarthritis of hand, hip, and knee. J Clin Rheumatol. 2016;22(7):345–354. doi:10.1097/RHU.0000000000000449.
  • McMahon SB, Dargan P, Lanas A, et al. The burden of musculoskeletal pain and the role of topical non-steroidal anti-inflammatory drugs (NSAIDs) in its treatment. Ten underpinning statements from a global pain faculty. Curr Med Res Opin. 2021;37(2):287–292. doi:10.1080/03007995.2020.1847718.
  • Sethi V, Van der Laan L, Gupta S, et al. Perspectives of healthcare professionals towards combination use of oral paracetamol and topical non-steroidal inflammatory drugs in managing mild-to-moderate pain for osteoarthritis in a clinical setting: an exploratory study. J Pain Res. 2022;15:2263–2272. doi:10.2147/JPR.S373382.
  • Kendrick DB, Strout TD. The minimum clinically significant difference in patient-assigned numeric scores for pain. Am J Emerg Med. 2005;23(7):828–832. doi:10.1016/j.ajem.2005.07.009.
  • Salaffi F, Stancati A, Silvestri CA, et al. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur J Pain. 2004;8(4):283–291. doi:10.1016/j.ejpain.2003.09.004.
  • Hsu JR, Mir H, Wally MK, et al. Clinical practice guidelines for pain management in acute musculoskeletal injury. J Orthop Trauma. 2019;33(5):e158–e182. doi:10.1097/BOT.0000000000001430.
  • Maher C, Underwood M, Buchbinder R. Non-specific low back pain. Lancet. 2017;389(10070):736–747. doi:10.1016/S0140-6736(16)30970-9.
  • McSwan J, Gudin J, Song XJ, et al. Self-healing: a concept for musculoskeletal body pain management – scientific evidence and mode of action. J Pain Res. 2021;14:2943–2958. doi:10.2147/JPR.S321037.
  • Chenot J-F, Greitemann B, Kladny B, et al. Non-specific low back pain. Deutsches Ärzteblatt Int. 2017;114(51–52):883.
  • Swann J. Good positioning: the importance of posture. Nurs Res Care. 2009;11(9):467–469. doi:10.12968/nrec.2009.11.9.43734.
  • Überall MA. Behandlung von akuten Kreuz-und Rückenschmerzen. Schmerzmedizin. 2021;37:51–54.
  • Takeda O, Chiba D, Ishibashi Y, et al. Patient-physician differences in desired characteristics of NSAID plasters: an online survey. Pain Res Manag. 2017;2017:5787854. doi:10.1155/2017/5787854.